Home

Charles Ross Carter

CIK 1779359 · Chief Financial Officer · last filed 2026-07-08

Charles Ross Carter is a Chief Financial Officer who has filed 9 SEC Form 4 insider transactions across 3 companies since 2021. The most recent filing, for OVID, was dated Jul 8, 2026. Across all open-market trades the lifetime net is +$49.4K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $209.5K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$209.5K

Companies

3

Total Filings

9

Lifetime Open-Market Net

$49.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
OVID Chief Financial Officer 94,375 $2.22 $209.5K $0 1 2026-07-08
CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Chief Financial Officer — $0.05 — $0 2 2024-07-01
ICAD INC (ICAD) Delisted CHIEF FINANCIAL OFFICER 7,000 $3.87 $27.1K $49.4K 4 2022-01-18

Recent Filings

9 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-08 OVID Grant (A) +50,000 $0 EDGAR
2024-07-01 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Grant (A) — $0 EDGAR
2024-03-27 CERO THERAPEUTICS HOLDINGS, INC. (PBAXW) Delisted Grant (A) — $0 EDGAR
2022-01-18 ICAD INC (ICAD) Delisted Grant (A) — $0 EDGAR
2022-01-12 ICAD INC (ICAD) Delisted Grant (A) — $0 EDGAR
2021-12-15 ICAD INC (ICAD) Delisted Buy (P) +7,000 $49.4K EDGAR
2021-08-04 ICAD INC (ICAD) Delisted Grant (A) — $0 EDGAR
2021-03-11 — Disp (D) — $0
2019-09-23 — Grant (A) — $0
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.